Skip to main content
Clinical Trials/DRKS00030574
DRKS00030574
Recruiting
Not Applicable

Biomarkers of thrombocyte activation as predictive factor for hemorrhagic complications of strokes occurring under platelet aggregation inhibition - PSC-BAT (Predicting Stroke Complications - Biomarker of Activated Thrombocytes)

Klinik für Neurologie, Universitätsklinikum Frankfurt, Goethe Universität0 sites100 target enrollmentJanuary 19, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I63
Sponsor
Klinik für Neurologie, Universitätsklinikum Frankfurt, Goethe Universität
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 19, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Neurologie, Universitätsklinikum Frankfurt, Goethe Universität

Eligibility Criteria

Inclusion Criteria

  • Clincal and/or radiological diagnosis of an acute ischemic or hemorrhagic stroke
  • \- Time from symptom onset or last seen well to hospital admission \<24h
  • \- Prior antithrombotic medication (aspirin, clopidogrel, ticagrelor, prasugrel, dipyridamol) or lack thereof (control group)

Exclusion Criteria

  • \- Prior oral anticoagulation (marcumar, dabigatran, apixaban, rivaroxaban, edoxaban) or heparin
  • \- Administration of intravenous thromboylsis prior to blood test
  • \- History of coagulation disorders (e.g. von Willebrand disease, Glanzmann\`s thrombasthenia, Bernard\-Soulier syndrome)

Outcomes

Primary Outcomes

Not specified

Similar Trials